Announce data from IND enabling toxicology study for KB407
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 7 Jan 2021
- Due
- 30 Jun 2021
- Delivered
- 19 Apr 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“1H21 KB407 for CF Announce data from IND enabling toxicology study in nonhuman primates”
What we found
Evidence strength A What the grades mean
The company announced positive preclinical data from the GLP toxicology and biodistribution study for KB407 on April 19, 2021, which is within the first half of 2021.
-
A Krystal Biotech, Inc. 10-Q filed 2021-08-09
“On April 19, 2021, we announced positive preclinical data from the Good Laboratory Practice toxicology and biodistribution study, in which the No-Observed-Adverse-Effect Level was determined to be the highest dose tested.” ✓ confirmed on the page
Market reaction: the shares moved -4.8% against the S&P 500 over the three sessions around the disclosure (6 Aug 2021 to 11 Aug 2021). What this measures
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Announce
- Deliverable
- KB407 toxicology study data
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Krystal Biotech, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-KRYS-021266 · Corrections policy